Skip to main content

Table 2 Prevalence of the comorbidities included in the Charlson Comorbidity Index score

From: Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

Comorbidity

Total = 1128

N (%)

Missing

N

Myocardial infraction

17 (1.5%)

1

Congestive heart failure

13 (1.2%)

0

Peripheral vascular disease

26 (2.3%)

3

Cerebrovascular accident or transient ischemic attack

10 (0.9%)

3

Dementia

1 (0.1%)

3

Chronic obstructive pulmonary disease (COPD)

35 (3.1%)

3

Peptic ulcer disease

14 (1.2%)

3

Liver disease (mild)

22 (2.0%)

3

Liver disease (moderate to severe)

2 (0.2%)

3

Diabetes mellitus (uncomplicated)

59 (5.2%)

0

Diabetes mellitus (with end-organ damage)

7 (0.6%)

0

Hemiplegia

0 (0.0%)

3

Chronic kidney disease (moderate - severe)

21 (1.9%)

6

Solid tumor (localized)

55 (4.9%)

3

Solid tumor (metastatic)

1 (0.1%)

3

Leukemia

1 (0.1%)

4

Lymphoma

3 (0.3%)

4

Acquired Immune Deficiency Syndrome (AIDS)

0 (0.0%)

4